Buradasınız

Anasayfa » Content

Sekonder Hemokromaoz ve Miliyer Tüberkülozlu Bir Hemodiyaliz Hastası

A Hemodialysis Patient With Secondary Hemochromatosis and Miliary Tuberculosis

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2005

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
While treatment with intravenous iron is essential for iron deficiency in hemodialysis patients, there is also evidence that links iron and iron overload with an increased risk of infection. In this article, we present a hemodialysis patient who develops secondary hemochromatosis and subsequent miliary tuberculosis.
Bookmark/Search this post with
Abstract (Original Language): 
Hemodiyaliz hastalarında demir eksikliğinin tedavisinde intra-venöz demir gerekli olmasına rağmen, demir tedavisi ve demir yüklenmesi ile infeksiyon riskinin artışı arasında ilişki olduğuna dair kanıtlar vardır. Biz bu makalede, tedavi sırasında sekonder hemokro-matoz ve arkasından miliyer tüberküloz gelişen bir hemodiyaliz hastasını sunuyoruz.
FULL TEXT (PDF): 
PDF icon pdf_tndt_527.pdf
  • 2
90-92
  • Turkish

REFERENCES

References: 

1. Brewster UC, Perazella MA. Intravenous iron and the risk of infection in end-stage renal disease patients. Semin Dial 2004;17:57-60.
2. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDI-
AL: a multicenter prospective study of risk factors for bac-teremia in chronic hemodialysis patients. J Am Soc Nephrol 1998;9: 869-876.
3. Schaible UE, Collins HL, Priem F, Kaufmann HE. Correction of the iron overload defect in fi2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med 2002;196(11):1507-1513.
4. Ali M, Fayemi AO, Rigolosi R, et al. Hemosiderosis in hemo-dialysis patients. An autopsy study of 50 cases. JAMA 1980;
244:343-345.
5. Seifert A, von Herrath D, Schaffer K. Iron overload, but not treatment with desferrioxamine favours the development of septicaemia in patients on maintenance hemodialysis. Q J
Med 1987;65:1015-1024.
6. Tielemans CL, Lenclud CM, Wens R, Collart FE, Dratwa M. Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections. Nephrol
Dial Transplant 1989;4:883-887.
7. Boelaert JR, Daneels RF, Schurges ML. Iron overload in ha-emodialysis patients increases the risk of bacteraemia: a prospective study. Nephrol Dial Transplant 1990;5:130-134.
8. NKF-K/DOQI Clinical Practice Guidelines for anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis
2001; 37(Suppl 1):182-238.
9. Macdougall IC, Horl WH, Jacobs C, et al. European best practice guidelines 6-8: assessing and optimizing iron sto¬res. Nephrol Dial Transplant 2000;15(Suppl 4):20-32.
10. Canavese C, Bergamo D, Ciccone G, et al. Validation of se¬rum ferritin values by magnetic suspectometry in predicting iron overload in dialysis patients. Kidney Int 2004;65:1091-
1098.

Thank you for copying data from http://www.arastirmax.com